Facts first. Jurisdiction matters.
TribuneCBD USA is the English-language US section of TribuneCBD, a France-based publication covering CBD, hemp and cannabis policy. The English edition is original reporting, not an automatic translation.
What we check
We prioritize enacted laws, regulations, courts and official federal and state agencies. Each legal explainer states its verification date and separates current law from proposed rules and future effective dates. Where a source is unavailable or conflicting, we say so or postpone the claim.
Different products, different rules
We distinguish hemp, CBD and marijuana; cultivation, possession, medical programs, retail, food, supplements, inhaled products and interstate transport are not interchangeable permissions. A laboratory result or a retailer’s claim does not establish legal compliance.
Health, commercial content and corrections
Our reporting does not diagnose, prescribe or promise a health benefit. Sponsored material must be identified and commercial links marked sponsored. Factual corrections can be sent to tribunecbd@gmail.com, with the article URL and the primary source.
Audience measurement & privacy
The US edition uses the existing TribuneCBD Google Analytics property only after you accept optional audience measurement. Refusing does not restrict access. Your choice is stored in this browser and shared with our French edition. We do not add advertising trackers or a separate US account. Country-level reporting is approximate and covers measured, consenting visits, not every visitor.
To change your choice, . This reloads the page and asks again.
See the publisher and legal information in French. No content is individual legal or medical advice. No indexing, ranking or traffic result is guaranteed.